Prof. Manon Hillegers (Erasmus MC Sophia, the Netherlands) explained that the Grow It! app monitors thoughts and emotions in daily life using the Experience Sampling Method (ESM) to identify emotion profiles and increase self-insight. It offers daily cognitive behavioural therapy (CBT)-based challenges to promote adaptive coping, and provides motivating gaming elements. The process of developing an app like this was long and full of numerous small steps.
“You participate anonymously, you choose a nickname, and you play for a team of 5–8 adolescents,” explained Prof. Hillegers. “Together, you grow a tree. You compete with other teams and earn points by completing questionnaires on emotion (ESM), which enhance insight into emotion, and by completing daily challenges, which help you to cope with stress.”
The Grow It! app was about to be released when the COVID-19 crisis broke out, upon which the longitudinal Grow It! COVID-19 study was carried out to evaluate the app. There were 3,153 participants (75% girls, mean age 17.9 years) in 2 cohorts. The first cohort was recruited during the first lockdown around May 2020 (n=1,282), the second around the time of the second lockdown in December 2020 (n=1,871). The results showed that affective and cognitive well-being at an individual level increased in 41–53% of adolescents.
Prof. Hillegers offered the following take-home messages from the Grow It! COVID-19 study:
- Adolescents at high risk for mood disorders have a distinct emotional profile and can be identified.
- Adolescents want to share but prefer not to talk about emotions.
- Smartphones can be used to reach out and to offer help and feedback on emotions to adolescents.
- Developing and testing gamified eHealth tools in co-creation with youth will enhance insight into needs, motivation, and better preventive effects.
- Hillegers MHJ. Connecting, challenging and empowering youth through their smartphone. S.21.02, ECNP 2021 Congress, 2–5 October.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Alcohol consumption during lockdown Next Article
Deep brain stimulation effective in the treatment of refractory OCD »
« Alcohol consumption during lockdown Next Article
Deep brain stimulation effective in the treatment of refractory OCD »
Table of Contents: ECNP 2021
Featured articles
Anxiety and Stress
Anxiolytic activity of a novel orexin-1 receptor antagonist
Autism
Finding biomarkers for improved patient stratification
Behavioural Disorders
Sex similarities and differences in the neurobiology of aggression
Risky driving and lifestyle may have a common psychobiological basis
Cannabidiol for cannabis cessation shows positive results
Somatic comorbidities of ADHD: epidemiological and genetic data
Novel approaches to understanding the social brain
COVID-19
Alcohol consumption during lockdown
Post-COVID-19 depression responds well to SSRIs
Impact of COVID-19 on patients with psychotic disorders
Mood Disorders
Depression and brain structures associations across a lifespan
BDNF/TrkB pathway promising alternative for new antidepressants
Zuranolone reduces symptoms of major depression
Vortioxetine effectively reduces symptoms of depression and anxiety
Esketamine outperforms real-world management for treatment-resistant depression: preliminary results
Smartphone interventions in bipolar disorder: a position paper
Connecting, challenging, and empowering youth through their smartphone
Personality Disorders
Evaluating vafidemstat for the treatment of borderline personality disorder
Deep brain stimulation effective in the treatment of refractory OCD
Psychotic Disorders
Why antipsychotics cause weight gain
Roluperidone improves negative symptoms in schizophrenia
Other
Brain Prize Lecture: Prof. Jes Olesen on migraine
Laxative may improve cognitive performance
Related Articles
November 26, 2021
Brain Prize Lecture: Prof. Jes Olesen on migraine
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com